Patents by Inventor Matthew Kimber

Matthew Kimber has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Novel Purified dihydrodipicolinate synthase polypeptides and structures thereof
    Publication number: 20070048814
    Abstract: The present invention relates to novel drug targets for pathogenic bacteria. Accordingly, the invention provides purified protein comprising the amino acid sequence set forth in SEQ ID NO: 4. The invention also provides biochemical and biophysical characteristics of the polypeptides of the invention.
    Type: Application
    Filed: September 12, 2005
    Publication date: March 1, 2007
    Applicant: Affinium Pharmaceuticals, Inc.
    Inventors: Aled Edwards, Akil Dharamsi, Matthew Kimber
  • Crystal structures of YHHF polypeptides
    Publication number: 20070010949
    Abstract: The present invention relates to novel drug targets for pathogenic bacteria. Accordingly, the invention provides purified protein comprising the amino acid sequence set forth in SEQ ID NO: 4. The invention also provides biochemical and biophysical characteristics of the polypeptides of the invention.
    Type: Application
    Filed: June 30, 2005
    Publication date: January 11, 2007
    Applicant: Affinium Pharmaceuticals, Inc.
    Inventors: Aled Edwards, Akil Dharamsi, Masoud Vedadi, Matthew Kimber
  • Crystal structures of aspartate semialdehyde dehydrogenases
    Publication number: 20070004020
    Abstract: The present invention relates to novel drug targets for pathogenic bacteria. Accordingly, the invention provides purified protein comprising the amino acid sequence set forth in SEQ ID NO: 4. The invention also provides biochemical and biophysical characteristics of the polypeptides of the invention.
    Type: Application
    Filed: June 30, 2005
    Publication date: January 4, 2007
    Applicant: Affinium Pharmaceuticals, Inc.
    Inventors: Aled Edwards, Akil Dharamsi, Masoud Vedadi, Matthew Kimber, Robert Lam
  • Crystal structures of NH3-dependent NAD synthetases
    Publication number: 20060079669
    Abstract: The present invention relates to novel drug targets for pathogenic bacteria. Accordingly, the invention provides purified protein comprising the amino acid sequence set forth in SEQ ID NO: 4. The invention also provides biochemical and biophysical characteristics of the polypeptides of the invention.
    Type: Application
    Filed: June 30, 2005
    Publication date: April 13, 2006
    Applicant: Affinium Pharmaceuticals, Inc.
    Inventors: Aled Edwards, Akil Dharamsi, Masoud Vedadi, Matthew Kimber, Robert Lam
  • Crystal structures of bacterial thymidylate kinases
    Publication number: 20060078976
    Abstract: The present invention relates to novel drug targets for pathogenic bacteria. Accordingly, the invention provides purified protein comprising the amino acid sequence set forth in SEQ ID NO: 8. The invention also provides biochemical and biophysical characteristics of the polypeptides of the invention.
    Type: Application
    Filed: May 5, 2005
    Publication date: April 13, 2006
    Applicant: Affinium Pharmaceuticals, Inc.
    Inventors: Aled Edwards, Akil Dharamsi, Masoud Vedadi, Teresa Clarke, Matthew Kimber
  • Novel purified polypeptides from enterococcus faecalis
    Publication number: 20060003432
    Abstract: The present invention relates to novel drug targets for pathogenic bacteria. Accordingly, the invention provides purified protein comprising the amino acid sequence set forth in SEQ ID NO: 4. The invention also provides biochemical and biophysical characteristics of the polypeptides of the invention.
    Type: Application
    Filed: January 31, 2005
    Publication date: January 5, 2006
    Applicant: Affinium Pharmaceuticals, Inc.
    Inventors: Aled Edwards, Akil Dharamsi, Masoud Vedadi, Bryan Beattie, Teresa Clarke, Matthew Kimber
  • Novel purified polypeptides from Pseudomonas aeruginosa
    Publication number: 20050245728
    Abstract: The present invention relates to novel drug targets for pathogenic bacteria. Accordingly, the invention provides purified protein comprising the amino acid sequence set forth in SEQ ID NO: 4. The invention also provides biochemical and biophysical characteristics of the polypeptides of the invention.
    Type: Application
    Filed: October 18, 2004
    Publication date: November 3, 2005
    Applicant: Affinium Pharmaceuticals, Inc.
    Inventors: Aled Edwards, Akil Dharamsi, Masoud Vedadi, Matthew Kimber, Francois Vallee
  • Peptidyl-tRNA hydrolase of Enterococcus faecalis
    Publication number: 20050239186
    Abstract: The present invention relates to novel drug targets for pathogenic bacteria. Accordingly, the invention provides purified protein comprising the amino acid sequence set forth in SEQ ID NO: 4. The invention also provides biochemical and biophysical characteristics of the polypeptides of the invention.
    Type: Application
    Filed: January 31, 2005
    Publication date: October 27, 2005
    Applicant: Affinium Pharmaceuticals, Inc.
    Inventors: Aled Edwards, Akil Dharamsi, Masoud Vedadi, Bryan Beattie, Matthew Kimber
  • Novel purified polypeptides from pseudomonas aeruginosa
    Publication number: 20050221462
    Abstract: The present invention relates to novel drug targets for pathogenic bacteria. Accordingly, the invention provides purified protein comprising the amino acid sequence set forth in SEQ ID NO: 4. The invention also provides biochemical and biophysical characteristics of the polypeptides of the invention.
    Type: Application
    Filed: October 14, 2004
    Publication date: October 6, 2005
    Applicant: Affinium Pharmaceuticals, Inc.
    Inventors: Aled Edwards, Akil Dharamsi, Masoud Vedadi, Megan Domagala, Matthew Kimber, Francois Vallee
  • Novel purified polypeptides from streptococcus pneumoniae
    Publication number: 20050214918
    Abstract: The present invention relates to novel drug targets for pathogenic bacteria. Accordingly, the invention provides purified protein comprising the amino acid sequence set forth in SEQ ID NO: 4. The invention also provides biochemical and biophysical characteristics of the polypeptides of the invention.
    Type: Application
    Filed: October 8, 2004
    Publication date: September 29, 2005
    Applicant: Affinium Pharmaceuticals, Inc.
    Inventors: Aled Edwards, Akil Dharamsi, Masoud Vedadi, Matthew Kimber
  • Novel purified polypeptides from Streptococcus pneumoniae
    Publication number: 20050187718
    Abstract: The present invention relates to novel drug targets for pathogenic bacteria. Accordingly, the invention provides purified protein comprising the amino acid sequence set forth in SEQ ID NO: 4. The invention also provides biochemical and biophysical characteristics of the polypeptides of the invention.
    Type: Application
    Filed: August 20, 2004
    Publication date: August 25, 2005
    Applicant: Affinium Pharmaceuticals, Inc.
    Inventors: Aled Edwards, Akil Dharamsi, Masoud Vedadi, Teresa Clarke, Matthew Kimber, Vivek Sharma, Simon Houston, Kamran Mansoury
  • Novel purified polypeptides from pseudomonas aeruginosa
    Publication number: 20050164362
    Abstract: The present invention relates to novel drug targets for pathogenic bacteria. Accordingly, the invention provides purified protein comprising the amino acid sequence set forth in SEQ ID NO: 4. The invention also provides biochemical and biophysical characteristics of the polypeptides of the invention.
    Type: Application
    Filed: June 21, 2004
    Publication date: July 28, 2005
    Applicant: Affinium Pharmaceuticals, Inc.
    Inventors: Aled Edwards, Akil Dharamsi, Masoud Vedadi, Muhammad Alam, Megan Domagala, Simon Houston, Matthew Kimber, Benjamin Pinder, Francois Vallee, Olga Wrezel, Donald Awrey, Bryan Beattie
  • Novel purified polypeptides from staphylococcus aureus
    Publication number: 20050164363
    Abstract: The present invention relates to novel drug targets for pathogenic bacteria. Accordingly, the invention provides purified protein comprising the amino acid sequence set forth in SEQ ID NO: 4. The invention also provides biochemical and biophysical characteristics of the polypeptides of the invention.
    Type: Application
    Filed: July 30, 2004
    Publication date: July 28, 2005
    Inventors: Aled Edwards, Akil Dharamsi, Masoud Vedadi, Simon Houston, Matthew Kimber
  • Novel purified polypeptides from Streptococcus pneumoniae
    Publication number: 20050158732
    Abstract: The present invention relates to novel drug targets for pathogenic bacteria. Accordingly, the invention provides purified proteins comprising amino acid sequences set forth within. The invention also provides biochemical and biophysical characteristics of the polypeptides of the invention.
    Type: Application
    Filed: June 18, 2004
    Publication date: July 21, 2005
    Applicant: Affinium Pharmaceuticals, Inc.
    Inventors: Aled Edwards, Akil Dharamsi, Masoud Vedadi, Muhammad Alam, Simon Houston, Matthew Kimber, Robert Lam, Ivy Ng, Benjamin Pinder
  • Protein data analysis
    Publication number: 20020120405
    Abstract: The disclosure includes a description of a method of data mining protein data. The method includes accessing data identifying respective outcomes associated with a set of proteins subjected to a set of conditions and analyzing the data based on the outcomes.
    Type: Application
    Filed: September 27, 2001
    Publication date: August 29, 2002
    Inventors: Aled Edwards, Cheryl Arrowsmith, Matthew Kimber, Mark Gerstein